An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

NCT00256113 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
467
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi